This is the Comprehensive Program in Clinical Trials Data Management and Pharmacovigilance Certificate course endorsed by Indian Biological-science and Research Institute and offered on Emagister.
It is an amazing opportunity to develop the skills required in this industry, it was designed to cover all aspects of Pharmacovigilance and drug safety management.
The Comprehensive Program in Clinical Trials Data Management and Pharmacovigilance Certificate course sensitizes the students and equips them with knowledge on Pharmacovigilance practices worldwide and on the Indian scenario in detail.
This course allows young executives to remain ahead of competitors in a very nascent yet competitive environment.
The prime objective is to provide high-end training thereby enhancing the employment prospects of the participants.
This course is suitable for: MBBS/BDS/BAMS/BHMS/B PHARMACY/ BVSC/BSc LIFE-SCIENCE/ BIOTECH/M PHARMA/MSc/M Tech/ MD etc.
If you want to learn more information about it, please do not hesitate to contact Indian Biological-science and Research Institute through Emagister.co.uk
Ist dieser Kurs für mich?
Course intended for keen interested students and professionals who want to enter and grow in this field.
Wie geht es nach der Info-Anfrage weiter?
On receiving your request for the program, our team member will contact you and assist you if you have any related query.
Voraussetzungen: Science graduate with similar work experience OR science post graduate Or working professionals in similar domain.
Distance Learning
Beginn
nach Wahl
Anmeldung möglich
These are the papers covered in this course-
Paper-I: Introduction to Clinical Trials
Paper-II: Introduction to Clinical Trials Data Management
Paper-III: Principles of Pharmacovigilance
Paper-IV: Biostatistics, SAS and Data Management
Paper-V: Computerized Systems for E- Case Report Form and Data Acquisition and Validation
Paper-VI: Methodologies in Pharmacovigilance and Signal Detection
Paper-VII: GCP, ICH, Ethics, IRB, Regulations for Clinical Trials
Paper-VIII: Pharmacovigilance Compliance and Management
Paper-IX: Case Study Report
